Introduction

38
Microfracture, first described by Steadman et al [1, 2] , permits bone marrow derived 39 mesenchymal stem and progenitor cells into a chondral defect site [3] by making small holes 40 through the subchondral bone plate to access the underlying subchondral bone marrow [4] .
41
The progenitor cells have a multipotent differentiation capacity that includes the ability to strategy. Growth factors used have included the bone morphogenic proteins (BMPs) [11, 12] , 59 transforming growth factors (TGF-βs) [ 
Methods
82
This study received approval from both local research ethics committee and the Home Office. Necropsy: Animals were humanely sacrificed at 13 or 26 weeks postoperatively using a 114 lethal dose of sodium pentobarbital.
115
Gross Morphology: The joints were photographed and the surface of the osteochondral 116 defect sites blindly scored using the International Cartilage Repair Society score (Table 2) . one investigator, using a modified O'Driscoll score (Table 3) .
133
Immunohistochemistry: Immunohistochemistry was performed as described previously [26] .
134
The following primary antibodies were used in this study; monoclonal mouse anti human bearing at 2 weeks post surgery (Fig 1a and b) and then a recovery in weight bearing with 167 time.
168
There was a significant difference between weight bearing in animals that received 0g between treatment groups (Fig. 2) .
178
Mechanical testing: At 6m there was no significant difference between the treatment groups,
179
either between the contralateral limb or the perilesional cartilage in the operated limb (Fig. 3) .
180
Quantitative Histology
181
Modified O'Driscoll total histology scores: All samples were scored using the modified
182
O'Driscoll score (Fig. 4) application of the membrane did not provide any protective effect to the repairing tissue.
241
Significant increases in healing were only detected in the presence of 6.4 and 32µg rhFGF-
242
18.
243
In this study, three components of healing were examined. In addition to the standard gross cartilage relative to the undamaged cartilage. In this study we did not find a statistically 248 significant difference between treatment groups, similar to that observed by our group in a 249 previous, similar study [16] . These results, taken together, indicate that durometer 250 measurements in this model may be of little functional value perhaps due to the influence of 251 the underlying bone.
252
In contrast, we have demonstrated that animals that received 32µg rhFGF-18, applied on a 253 membrane at the point of surgery, had significantly increased weight bearing on the operated 254 leg at weeks 2 and 4 post surgery compared to controls and had returned to pre-operative 255 levels of weight bearing by week 8 post surgery. The timing of this increased weight bearing 256 is likely to be too early to be attributed to enhanced healing of the defects and may, perhaps,
257
indicate that rhFGF-18 might have analgesic actions post surgery. However, it must be noted 258 that the sample size used in the study (n=5 per experimental group) was determined using a 259 power calculation designed to allow differences in histological features, not joint loading.
260
Further work is needed in this area to establish the validity of the observation and the 261 mechanisms underlying it.
262
Improving the quantity and quality of microfracture repair tissue is a clear clinical need [8] .
263
In this, and a previous study [ 
308
There is no significant difference between the two groups. * = significant difference at this 309 time point. 
